Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Paraffin hard
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
3 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(1)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 1 · 1982–2026
Showing the 50 most relevant studies, sorted by most relevant.
S. Shi, B. Chaiwun, L. Young, et al.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 1993
I. Krupa, G. Miková, A. S. Luyt
European Polymer Journal, 2007
S. Carlquist
Stain technology, 1982
F. S. A. Majeed, N. Yusof, M. A. Suhaimi
Advances in Lightweight Materials and Structures, 2020
A. Khimchenko, C. Bikis, A. Pacureanu, et al.
Advanced Science, 2018
H. Ratech, J. Burke, D. Blayney, et al.
Cancer, 1989
Yunxia Guo, Junjie Ma, Zhengyue Li, et al.
Analytica chimica acta, 2023
Kevin A. Redosado Leon, A. Lyulin, B. Geurts
Polymers, 2024
Xiuyu Wang, Huseyn Gurbanov, Mehpara Adygezalova, et al.
2024
Asphaltene-resin-paraffin deposition (ARPD) is a complicated and prevalent issue in oil and gas industry, impacting the efficiency, integrity of petroleum extraction, production, transportation and processing systems. Considering all witnessed ARPD problems in Azerbaijan oil fields, this paper proposed a chemical method and optimized the type and the concentration of chemical inhibitors. And then the effect of selected chemical reagent on inhibiting the ARPD amount and thus en-hancing oil recovery was detected by reservoir simulation during both waterflooding and CO2 flooding production. Three new chemical compounds (namely, Chemical-A, Chemical-B and Chemical-C) were examined in laboratory conditions and their impact on rheological properties of high-paraffin oilfield samples of Azerbaijan (X, Y and Z) were investigated. Experimental results show that Chemical-C with concentration of 600 g/t has the best efficiency for alleviating the problems. After adding Chemical-C to the crude oil, the freezing point of oil is decreased from 12 °C to (-4) °C, ARPD amount is declined from 0.185 to 0.016 g and oil effective viscosity is reduced from 16.2 mPa·s to 3.1 mPa·s. It is determined that for water and CO2 flooding, higher injection pressure resulted in reduced asphaltene precipitation. Adding selected ARPD inhibitor, the oil recovery for waterflooding can increase from 52% to 62%, while it can rise from 55% to 68% for CO2 flooding.
Abstract licence: CC BY 4.0
Liu X, Ding Y, Ren J, et al.
2025
Objectives: This study aimed to determine the factors affecting the diagnostic efficacy of frozen sections for assessing tumor spread through air spaces (STAS) and to provide suggestions for the sampling of these frozen sections. Methods: Cases of invasive adenocarcinoma with a pathological diagnosis of stage IA-IIIB were screened, and frozen and paraffin sections were reviewed. Using paraffin sections as the gold standard, the consistency of frozen pathological diagnosis of STAS was calculated. Factors that may affect STAS diagnosis in frozen sections were screened, and a nomogram was drawn. Results: The sensitivity of frozen sections in STAS diagnosis was 55.4% (108/195), the specificity was 74.5% (254/321), and the kappa value was 0.35. In the subsequent logistic regression, the ratio of the tissue diameters of the frozen and paraffin sections, number of frozen section sheets, clarity of the tumor boundary, and number of alveoli from the peritumoral area to tissue edge were all statistically significantly significant (p Conclusions: The diagnostic efficacy of frozen sections for STAS is poor. In our study, the tissue diameter ratio of the frozen to paraffin sections, the number of frozen sections, the clarity of the tumor boundary, and the number of alveoli from the peritumoral tissue to the tissue edge were considered independent factors affecting diagnostic consistency. The accuracy of the frozen section analysis in STAS diagnosis can be improved by our reasonable suggestions on frozen sampling, making it a reliable indicator of the surgical method.
Abstract licence: CC BY
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.